The Efficiency and Safety of Olopatadine against Rupatadine in Chronic Urticaria of Idiopathic Origin: A Comparative Study
Syeda Ayesha Siddiqua1,  Md. Zubair Ahmed2*and Abdullah Ansari3

1Department of Pharmacology, Shadan Institute of Medical Sciences, Teaching Hospital and Research Centre, Hyderabad – 500008, Telangana, India.

2Department of Pharmacology, Mamata Academy of Medical Sciences, Bachupally, Hyderabad – 500090, Telangana, India.

3Department of Pharmacology, Ayaan Institute of Medical Sciences, Teaching Hospital and Research Centre, Hyderabad- 501504, Telangana, India.

Corresponding Author E-mail : drzubair8880@yahoo.co.in

Abstract: Background: Urticaria has a wide spectrum of clinical presentations and causes. Patients with urticaria make up a large proportion of referrals to allergy clinics. Urticaria is characterized by wheals with swelling which can appear on any body part. This study is attempted to match the efficiency and safety of olopatadine with rupatadine in the treatment of chronic urticaria of idiopathic origin. Methods: Based on the inclusion and exclusion criteria, sixty patients of urticaria were divided into two treatment groups, olopatadine, and rupatadine groups. The groups received olopatadine and rupatadine, orally with doses of 10mg/day respectively, for 8weeks. Clinical improvement was evaluated through parameters in terms of change in Absolute Eosinophil Count (AEC), serum IgE level, Total Symptom Score (TSS), and safety was considered on the adverse events reported. Results: AEC was considerably depressed by both drugs but the olopatadine group was superior in its action. Within the olopatadine group, a greater decline in the serum IgE level is observed than that of the rupatadine group. Olopatadine was found to be better in the reduction of TSS. The prevalence of adverse effects (gastric irritation, drowsiness, headache, and dryness of mouth) was less in the olopatadine group when compared to the rupatadine group. Conclusions: From the analysis of results, the study shows that olopatadine is a better choice in the treatment of chronic urticaria of idiopathic origin in comparison to rupatadine as a result of its better efficiency and safety profile.

Keywords: Absolute Eosinophil Count; Chronic Urticaria of Idiopathic Origin; Olopatadine; Rupatadine; Serum IgE; Total Symptom Score

[ HTML Full Text]

Back to TOC